How Do I Raise Money From U.S. Investors?

  • Foreign founders can raise money from U.S. investors, but entity structure, investor requirements, and securities compliance determine the workable path.
  • Startups usually raise through a SAFE agreement, convertible note, or priced round, with different valuation, repayment, and dilution terms.
  • A foreign company can often issue a SAFE to a U.S. investor, though many institutional investors require a Delaware corporation.
  • A Delaware flip may be appropriate before fundraising when investors expect U.S. preferred stock, familiar governance, and a clean cap table.
  • Regulation D, Form D filing, state blue-sky rules, and tax treatment may apply. Legal and tax advice depends on the founder’s jurisdictions and facts.

What it actually takes to raise from U.S. investors

Raising money from U.S. investors requires you to make three decisions in sequence. You must choose the entity that will receive the investment, select a financing instrument, and comply with applicable securities laws. Each decision affects investor acceptance, legal cost, tax treatment, and future dilution.

First, decide which company will issue the securities. A foreign company can sometimes raise directly from a U.S. investor, including through a locally adapted SAFE. However, many U.S. venture funds expect a Delaware C corporation because its governance, preferred stock, and financing documents follow familiar standards. If institutional investment is likely, completing a Delaware flip before accepting funds may prevent difficult changes to shares, intellectual property, contracts, and existing investment instruments later.

Second, choose an instrument that fits the round. Early seed investors often use a SAFE agreement or convertible note because both postpone the priced valuation until a later financing. A convertible note creates debt and usually carries interest and a maturity date. A SAFE generally has no interest or maturity date. Larger seed rounds and most Series A financings use a priced round, where investors purchase preferred stock at an agreed valuation and negotiate governance and investor rights.

Third, treat fundraising as a securities offering. A U.S. investor’s purchase of a SAFE, note, or stock usually requires an exemption from registration, commonly under Regulation D. The company may also need a Form D filing, state blue-sky notices, board approvals, accurate cap table records, and investor qualification documents. A Delaware entity does not remove these obligations.

Before selecting a path, identify where the current company and founders are located, which investors you plan to approach, and whether those investors require a U.S. parent. Then consider the expected round size, the company’s existing shareholders and SAFEs, and the timing of a future priced round. Legal and tax advice depends on the jurisdictions involved and the founder’s specific facts.

Decision framework: which path fits your situation

Choose your fundraising path by starting with the entity investors will fund, then select the instrument that fits the round.

  • If you already have a Delaware C corporation and you are raising an early seed round from accredited investors, consider a SAFE. SAFEs usually require less negotiation than priced equity and postpone valuation until a later financing. Review the SAFE terms, dilution, Regulation D exemption, and filing obligations before accepting funds.
  • If you already have a Delaware C corporation and investors want interest, a maturity date, or repayment rights, consider a convertible note. Notes create debt until they convert or receive repayment, which adds obligations that a SAFE does not impose.
  • If a lead investor wants a negotiated valuation and governance rights, prepare for a priced round. Larger seed rounds and Series A financings commonly involve preferred stock, investor rights, board arrangements, and detailed closing documents.
  • If you have a foreign company and U.S. investors expect a Delaware issuer, evaluate a Delaware flip before signing financing documents. The reorganization must address foreign shareholders and existing SAFEs. It may also require transfers of intellectual property or operating contracts.
  • If you have a foreign company and the investor will fund that entity, a foreign-company SAFE or note may work. Local corporate law must permit the instrument, and the offering must comply with applicable U.S. securities rules. Tax treatment, withholding, and treaty questions depend on the countries involved.
  • If prospective investors include non-accredited individuals or you plan public solicitation, speak with securities counsel before marketing the round. Investor eligibility and solicitation methods affect which Regulation D exemption may be available.
  • If you have existing investors, option holders, or multiple classes of securities, clean up the cap table before choosing an instrument. Conversion terms and reorganization mechanics can produce unexpected dilution if the records are incomplete.

The later sections explain each financing instrument, foreign-entity SAFEs, Delaware flips, and U.S. offering compliance in more detail. Legal and tax advice depends on your jurisdictions and specific facts.

SAFEs, convertible notes, and priced rounds compared

Your financing instrument determines whether investors receive equity immediately or convert their investment later. It also affects negotiation time, legal cost, dilution, and investor protections.

Instrument How it works Valuation and dilution Investor protections Best for
SAFE The investor provides cash now. The SAFE converts into shares when a qualifying equity financing or another specified event occurs. SAFEs usually carry no interest and have no maturity date. A valuation cap, discount, or both determine the conversion price. Founders see the final dilution when the SAFE converts. Investors may negotiate most-favored-nation rights and pro rata rights. A SAFE usually provides fewer enforcement rights than debt. Best for early seed rounds when the company wants a relatively short document and can defer a priced valuation.
Convertible note The investor lends money to the company. The principal and accrued interest usually convert into shares during a later financing. A cap or discount usually sets the conversion economics. Interest increases the amount that converts. The note includes a maturity date and creditor rights. Investors may request repayment or renegotiation if no conversion occurs before maturity. Best for bridge financing or investors who want debt protections before conversion.
Priced equity round The company sells shares at an agreed price. Institutional investors usually purchase preferred stock. The parties establish the company valuation before closing. The company can calculate dilution before issuing the shares. Investors may negotiate liquidation preferences, voting rights, information rights, board representation, and pro rata rights. Best for larger seed or Series A rounds with a lead investor and negotiated governance terms.

A valuation cap sets the maximum company valuation used to calculate conversion. A discount reduces the next round’s share price by an agreed percentage. When an instrument includes both terms, the investor commonly receives whichever calculation produces the lower conversion price, subject to the document.

For example, assume a priced round sells shares for $2 each. A SAFE with a 20 percent discount converts at $1.60 per share. If the company has five million shares on a fully diluted basis, a $6 million valuation cap produces a $1.20 conversion price. The cap gives the investor the better price in this example, so a $120,000 SAFE would convert into 100,000 shares rather than 75,000 shares under the discount.

An MFN provision lets an investor adopt specified, more favorable terms that the company later gives another investor. For example, an early investor holding an uncapped MFN SAFE may elect a later SAFE’s $8 million cap. The signed document controls which later terms qualify and whether the investor can select individual terms or must adopt the later instrument as a package.

Founders should compare dilution across all outstanding SAFEs and notes before choosing an instrument. A short financing document can still create unexpected ownership changes when several conversion terms operate at the next priced round.

Can a foreign company issue a SAFE to a U.S. investor?

Yes. A foreign company can issue a SAFE to a U.S. investor if its home-country law permits the arrangement and the offering complies with applicable U.S. securities laws. The parties usually need a customized agreement because standard U.S. SAFE forms assume a Delaware corporation, Delaware corporate concepts, and future issuance of U.S. capital stock.

Most institutional U.S. investors prefer a Delaware C corporation and a Delaware-law SAFE. Familiar documents reduce uncertainty around conversion mechanics, preferred stock, governance, and enforcement. Funds may also avoid foreign companies because their investment mandates or tax policies restrict foreign holdings. A lead investor may therefore require a Delaware flip before closing or make funding conditional on completing one.

A foreign-entity SAFE can still work for an angel round when the investor accepts the jurisdiction and the company expects to remain foreign. Local counsel should confirm that the company can promise future equity and identify which securities the investor receives upon conversion. The SAFE must also address local equity classes, corporate approvals, currency, liquidation events, dispute resolution, and a possible later reorganization. Copying a Delaware template can leave conversion terms that do not function under local law.

An offering to a U.S. investor remains subject to U.S. securities law even when the issuer sits abroad. The company needs an available registration exemption, which may involve Regulation D, a Form D filing, and state notice filings. Regulation S alone generally does not cover a sale made to an investor in the United States. The investor’s accredited status, solicitation methods, and location can affect the available exemption.

Tax treatment requires separate analysis before signing. U.S. tax law does not always classify every SAFE consistently as equity, debt, or another type of contractual right. A foreign issuer can create additional questions involving withholding, treaty eligibility, foreign tax reporting, and possible PFIC or CFC consequences for U.S. holders. Conversion, repayment, dividends, and sale proceeds may receive different treatment.

Founders should compare the cost of customizing a foreign SAFE with the cost of restructuring before the round. Zecca Ross Law Firm can coordinate U.S. securities work, Delaware formation, and cross-border SAFE planning with local tax and corporate counsel. Legal and tax advice depends on the company’s jurisdiction, investor profile, and specific transaction terms.

When a Delaware flip should happen — and what it involves

A Delaware flip usually places a new Delaware C corporation above the existing foreign company. Foreign shareholders exchange their shares for shares in the Delaware parent, and the foreign company becomes its subsidiary. Investors then purchase SAFEs, notes, or preferred stock issued by the Delaware parent.

Founders should complete the flip before fundraising when U.S. institutional investors require a Delaware issuer. An early flip works best when the company has a simple cap table, limited commercial operations, and few existing financing instruments. Completing the reorganization before investors begin diligence also gives counsel time to document ownership and resolve local approvals without delaying a financing.

A flip completed after an initial raise requires more coordination. Existing shareholders must receive the correct number and class of Delaware shares while preserving vesting terms and other negotiated rights. Local corporate law may require shareholder approvals, filings, valuations, or exchange-control clearance. A share exchange can also create tax consequences even when shareholders receive no cash.

Intellectual property requires separate attention because ownership does not move automatically with the shares. Founders may assign the intellectual property to the Delaware parent or leave it with the foreign subsidiary under an intercompany license. Tax, transfer-pricing, government grant, and local regulatory considerations influence that choice. Employment agreements and invention assignments should support the selected ownership structure.

Commercial contracts also remain with their original legal entity unless the parties transfer them. Some customer agreements, leases, licenses, debt documents, and payment-provider accounts require consent before assignment or novation. Founders should identify those restrictions before choosing a closing date. The foreign subsidiary may continue performing local contracts after the flip, while the Delaware parent signs new investor and commercial agreements.

Existing SAFEs and convertible notes do not automatically become obligations of the Delaware parent. Counsel typically amends, exchanges, or terminates and replaces each instrument with investor consent. The replacement documents should preserve the negotiated valuation cap, discount, MFN rights, and pro rata rights where applicable. Currency differences and revised capitalization definitions can otherwise change the conversion economics.

Founders may reasonably delay a flip when local grants, licenses, tax incentives, or regulatory approvals depend on the current ownership structure. Delay may also make sense when early investors accept the foreign issuer and a U.S. institutional round remains uncertain. However, each new shareholder, SAFE, contract, or intellectual property asset can make a later reorganization more expensive and time-consuming.

Zecca Ross Law Firm helps non-U.S. founders evaluate and execute Delaware flips with direct attorney involvement and predictable flat-fee or capped-fee scopes. Legal and tax advice depends on the founders’ jurisdictions, ownership, operations, and financing documents.

Accredited investors, Regulation D, and Form D

A SAFE, convertible note, or share purchase gives an investor a security. A company offering that security in the United States must register the offering or qualify for an exemption. Most private startup rounds rely on Regulation D, particularly Rule 506(b) or Rule 506(c).

An accredited investor meets a category defined by federal securities law. An individual commonly qualifies through net worth exceeding $1 million, excluding a primary residence, or annual income above $200,000 individually or $300,000 with a spouse or partner for the prior two years, with a reasonable expectation of the same income in the current year. Certain licensed investment professionals also qualify. Companies, trusts, funds, and other entities can qualify under separate tests based on assets, investments, ownership, or institutional status.

Rule 506(b) usually fits rounds raised through existing investor relationships. The company cannot use general solicitation, including unrestricted public advertising. Accredited investors may generally confirm their own status, although the issuer should document a reasonable compliance process. The rule permits up to 35 sophisticated non-accredited purchasers, but their participation creates additional disclosure duties and legal risk. Early-stage companies commonly limit a 506(b) round to accredited investors for that reason.

Rule 506(c) permits public solicitation, including online promotion of the offering. Every purchaser must be accredited, and the company must take reasonable steps to verify that status. A checkbox or unsupported representation may not satisfy the verification requirement.

A company relying on Regulation D generally files Form D electronically with the Securities and Exchange Commission within 15 calendar days after the first sale. Form D reports basic information about the issuer, offering size, exemption, executives, and sales compensation. The filing does not represent SEC approval, and Regulation D does not remove federal anti-fraud obligations.

State blue-sky compliance accompanies the federal exemption. Rule 506 generally preempts state registration requirements, but states may require notice filings, consent forms, and filing fees where investors reside. Arizona and California investors can therefore create separate state filing tasks even when a Delaware company uses one federal exemption.

Foreign issuers should not assume that foreign incorporation avoids these rules. Offers and sales involving U.S. investors may trigger U.S. securities requirements alongside the issuer’s home-country laws. Counsel should confirm the exemption, solicitation method, investor verification, Form D filing, and state notices before accepting funds. Legal and tax advice depends on the issuer’s jurisdictions and specific facts.

Cap tables, preferred stock, and founder dilution

A cap table records who owns the company on a fully diluted basis, including issued shares and securities that may convert into shares. Each SAFE conversion, option pool increase, and new stock issuance changes the ownership percentages even when founders keep the same number of shares.

Consider a simplified company with 9 million founder shares and a SAFE that converts into 10 percent of the company immediately before Series A. The SAFE receives 1 million shares upon conversion. Series A investors then purchase 20 percent of the company on a post-money basis, which requires the company to issue 2.5 million new shares.

Holder Before SAFE conversion After SAFE conversion After Series A
Founders 100% 90% 72%
SAFE investor 0% 10% 8%
Series A investors 0% 0% 20%
Total shares 9,000,000 10,000,000 12,500,000

The Series A issuance dilutes every existing holder by 20 percent. Founders fall from 90 percent after the SAFE conversion to 72 percent after the round. The SAFE investor falls from 10 percent to 8 percent. Actual calculations depend on the SAFE terms, financing valuation, capitalization definition, and any option pool increase required as part of the round.

Option pool negotiations can shift additional dilution toward founders and existing investors. If the Series A term sheet requires the company to expand its employee option pool before the investment closes, the new pool usually enters the pre-money capitalization. Founders and SAFE holders then absorb that dilution before the Series A investors calculate their post-closing percentage.

Founders usually hold common stock, while priced-round investors purchase preferred stock. Common stock carries voting and economic rights under the charter, but preferred stock may receive liquidation preferences, conversion rights, protective provisions, and other negotiated protections. A SAFE may convert into preferred stock or a related class when the priced round closes.

Zecca Ross reviews capitalization definitions and models conversion outcomes before founders sign financing documents. A precise cap table helps founders understand dilution and negotiate with actual percentages rather than headline valuations alone.

Investor rights: board seats, information rights, and pro rata

Priced rounds usually give major investors contractual rights that extend beyond their preferred stock. Seed investors may receive limited information and pro rata rights, while a Series A lead commonly negotiates formal reporting, board participation, and approval rights over specified corporate actions.

Pro rata rights let an investor buy enough securities in a later financing to preserve its ownership percentage. If an investor owns 10 percent before the next round, a standard pro rata right generally permits it to purchase 10 percent of the new securities. The investor may decline, and the right usually applies only while the investor meets an ownership threshold. Some SAFE investors receive pro rata rights through a side letter before any priced round.

Information rights require the company to provide financial statements, budgets, and other operating information on an agreed schedule. A small seed round may reserve these rights for the lead investor or investors above a minimum ownership level. Series A investors commonly request quarterly financial statements, annual reports, inspection rights, and advance delivery of the company’s budget. Companies often negotiate confidentiality duties and restrictions for investors connected to competitors.

Board rights give an investor direct involvement in corporate governance. An observer may attend meetings and receive board materials but cannot vote. A director can vote on matters such as executive hiring, financing plans, and major transactions. Seed leads sometimes receive observer status, while smaller SAFE holders usually receive no board role.

A Series A lead often requests one preferred-stock director seat. For example, a three-person board might include one founder director, one investor director, and one independent director approved by both sides. The independent seat can become decisive when the founder and investor disagree.

Founders should evaluate board composition together with preferred-stock protective provisions. A founder may hold most board seats but still need preferred-stock approval to issue senior securities, sell the company, or amend charter rights. Information and pro rata rights usually create less direct control risk, although they can increase reporting work and affect allocations in later rounds. Board voting rights and investor vetoes have a more immediate effect on who can authorize major decisions.

Financing instrument comparison table

Use this table to compare the financing instruments before choosing one for a U.S. fundraising round.

Factor SAFE Convertible note Priced equity round
Typical use case Pre-seed or seed financing when you want simpler documents and no maturity date Seed or bridge financing when investors expect debt terms Larger seed or Series A financing with a negotiated valuation
Valuation mechanism Converts later using a valuation cap, discount, or MFN provision Converts later using a valuation cap or discount, while accruing interest Sets the company’s valuation and share price when the investment closes
Investor protections Usually limited, although investors may negotiate pro rata or information rights Interest, maturity date, conversion rights, and possible repayment rights Preferred stock rights may include liquidation preference, voting rights, information rights, pro rata rights, and board representation
Dilution timing Founder dilution becomes visible when the SAFE converts, although post-money SAFEs can make the expected dilution easier to calculate Founder dilution becomes visible when the note converts Founder dilution occurs when the preferred shares are issued
Filing and compliance burden Lower document burden, but securities exemptions, Form D, and state filings may apply Moderate document burden, with securities filings and debt-related terms to manage Highest document and governance burden, with amended charter documents, securities filings, investor agreements, and closing approvals

Jurisdiction-specific notes for Arizona and California founders

A Delaware incorporation does not replace state securities compliance in Arizona or California. Rule 506 offerings under Regulation D generally avoid state-level registration, but each state may still require a Form D notice filing, consent to service, and filing fee. California filings go through the Department of Financial Protection and Innovation. Arizona filings go through the Arizona Corporation Commission’s Securities Division. Both states generally tie Rule 506 notice deadlines to the first sale to an investor in that state.

The investor’s residence usually drives the blue-sky analysis. A California founder who sells a SAFE only to an Arizona investor should review Arizona notice requirements. If the company relies on a state exemption instead of Rule 506, different eligibility, disclosure, and filing rules may apply. California’s exemption under Section 25102(f), for example, has conditions that differ from a federal Rule 506 offering.

Operating location creates separate corporate and tax obligations. A Delaware corporation conducting business in California or Arizona may need to register as a foreign corporation and maintain state tax, payroll, employment, and annual filing compliance. California can impose franchise-tax obligations when a company conducts business there, even though Delaware remains its incorporation state.

Zecca Ross helps founders coordinate federal filings with Arizona and California requirements. Counsel should review each offering based on the company’s activities, investor locations, exemption, and filing dates.

How Zecca Ross helps founders raise from U.S. investors

Zecca Ross Law Firm helps U.S. and international founders prepare the legal structure required for startup fundraising. Senior attorneys advise on Delaware C-corp formation, SAFE rounds, cap table setup, and cross-border reorganizations. The firm also handles Delaware flips involving foreign shareholders, intellectual property, commercial contracts, and existing SAFEs.

Cross-border fundraising requires judgment about when to reorganize and how each step affects the company. Zecca Ross can evaluate whether a foreign entity should raise directly or place a Delaware parent above the existing company. The firm can then prepare the corporate approvals and financing documents that reflect the chosen structure.

Template platforms such as Clerky and promise.legal can generate standard documents, but templates cannot determine whether a standard structure fits a founder’s tax position, existing ownership, or investor expectations. Zecca Ross provides direct senior-attorney access for founders who need advice on those choices. That guidance can be particularly useful when a company has operations or founders in Arizona or California but plans to raise through a Delaware corporation.

Flat-fee and capped-fee scopes give founders a defined legal work plan and more predictable billing than open-ended hourly engagements. Those arrangements connect the fee to an agreed scope rather than treating legal review as document generation.

Founders can contact Zecca Ross before accepting investor funds or signing a SAFE term sheet. Early review can identify structural, cap table, and documentation issues before they become embedded in a financing. Legal and tax outcomes depend on the company’s jurisdictions, investor profile, ownership structure, and specific facts, and counsel cannot promise funding or investment results.

FAQs

  • Do I need a Delaware entity before I can accept money from a U.S. investor? No. A foreign company can accept U.S. investment if the offering complies with applicable U.S. securities laws and its home-country law. However, institutional investors often require a Delaware C corporation before investing because familiar corporate law, preferred stock terms, and standard financing documents reduce uncertainty.
  • What happens to my existing SAFEs in a Delaware flip? Existing SAFEs do not automatically move to the new Delaware parent. The parties may amend, exchange, cancel and replace, or assign them, depending on their terms and local law. Counsel should preserve each investor’s valuation cap, discount, and other negotiated rights while checking consent and tax requirements.
  • Do I owe U.S. tax if I am a foreign founder raising a SAFE? SAFE proceeds received by a company generally function as financing rather than operating revenue, but U.S. tax treatment can depend on how the SAFE is characterized. A Delaware flip, intellectual property transfer, share exchange, or founder stock issuance may create separate tax consequences. The answer depends on the founder’s residence, the company’s jurisdiction, applicable treaties, and the transaction documents.
  • Can non-accredited U.S. investors participate? Sometimes. A Rule 506(b) offering may include up to 35 non-accredited investors who meet applicable sophistication requirements, but the issuer then faces added disclosure obligations. Rule 506(c) permits only verified accredited investors. Other exemptions may apply, so founders should select the exemption before accepting funds.
  • How long does a Delaware flip take? A simple flip can take several weeks, while a transaction involving numerous shareholders, existing SAFEs, regulated contracts, or local tax approvals may take longer. Zecca Ross Law Firm can scope the reorganization, cap table work, and financing documents under flat-fee or capped-fee arrangements. Legal and tax advice depends on the relevant jurisdictions and specific facts.

Conclusion

Entity and document choices made before the first investment often determine how smoothly later rounds proceed. A poorly planned foreign-entity SAFE, incomplete cap table, or delayed Delaware reorganization can create avoidable work when institutional investors begin diligence.

Qualified counsel should review the company structure, ownership records, intellectual property, contracts, and financing documents before you accept capital. Zecca Ross Law Firm provides senior-attorney guidance for cross-border founders through predictable flat-fee or capped-fee engagements. Legal and tax advice depends on each founder’s jurisdictions and specific facts.

Let's Work Together!

Legal clarity starts here. Partner with Zecca Ross Law Firm to transform complexity into opportunity.